In our last post, we discussed how Cannabis 2.0 is changing the Canadian cannabis industry, but how does AirMed power this product innovation?
With the legalization of derivative products like edibles, vapes, and topicals, a world of opportunity has opened up for licensed producers. To thrive in this evolving market, Canadian companies—from large-scale operations to nimble micro-processors—need a flexible cannabis management system. This is where AirMed comes in BY providing a comprehensive solution designed to handle the complexities of Cannabis 2.0 while ensuring compliance every step of the way.
Meeting the Unique Challenges of Cannabis 2.0
Producing derivative cannabis products is more complex than simply growing and packaging dried flower. It involves intricate manufacturing processes, strict quality control, and detailed record-keeping. AirMed software is specifically designed to handle these challenges.
Manufacturing and Processing: AirMed offers unique workflows for each product type, from edibles and beverages to vapes and concentrates. The system tracks every step of your production process, from sourcing raw materials to extraction and final packaging. This ensures you have a complete audit trail for Health Canada inspections.
Inventory and Batch Tracking: With Cannabis 2.0 products, precision is everything. AirMed tracks weights to five decimal places and allows you to manage batches and lots with unique identifiers. This is critical for maintaining consistency and accuracy, especially with products that have a regulated THC and CBD content per package. Our software supports the creation of discrete units like pre-rolls and gel caps, as well as bulk products for sale to other licensed producers.
Compliance and Reporting: The regulations for Cannabis 2.0 products are extensive, covering everything from ingredient lists to packaging requirements and THC limits. AirMed automates the data collection for Health Canada’s Cannabis Tracking and Licensing System (CTLS) reports, simplifying the compliance process. Our software ensures you can meet all federal, provincial, and even international standards (like the USA’s FDA 21 CFR Part 11 and EU GMP).
The Bottom Line: A Solution to Cultivate Success
The Cannabis 2.0 market is driven by consumer demand for diverse and innovative products. By using AirMed, Canadian licensed producers can streamline their operations, reduce compliance risks, and focus on what they do best: creating high-quality cannabis products.
Whether you are a large-scale standard processor introducing a new line of infused products or a micro-cultivator crafting artisanal strains, the AirMed platform offers the tools you need. Our software provides the foundation of efficiency and control needed to not only survive but to thrive in this exciting new chapter of the Canadian cannabis industry.
To learn more about how AirMed powers Cannabis 2.0 innovation for Canadian producers, visit our Software page.